Rosetta’s Predictive Ability for Low-Affinity Ligand Binding in Fragment-Based Drug Discovery is a research paper published in Biochemistry (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Deutsche Forschungsgemeinschaft
Grant: SFB1423 - 421152132
National Institutes of Health
Grant: F31 CA243353
National Institutes of Health
Grant: F31 GM133134-02
National Institutes of Health
Grant: R01 DA046138
National Institutes of Health
Grant: R01 GM080403
National Institutes of Health
Grant: T32 GM 8320-09
NIGMS NIH HHS
Grant: T32 GM008320
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01DA046138-04
Structural Determinants of Allosteric Modulation of Brain GPCRs
National Institutes of Health
Grant: 3R01GM080403-03S1
Membrane Protein Structure Elucidation from sparse NMR data (KAMP)
National Institutes of Health
Grant: 5F31CA243353-03
Hybridized structure- and ligand- based drug discovery approaches targeting ASCT2, an amino acid transporter critical for upregulated cell proliferation in numerous cancer types
Alexander von Humboldt-Stiftung
Pharmaceutical Research and Manufacturers of America Foundation
FWCI
0.70
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals